Quantification of impairment in MS: discussion of the scales in use
- 1 August 1999
- journal article
- research article
- Published by SAGE Publications in Multiple Sclerosis Journal
- Vol. 5 (4) , 216-219
- https://doi.org/10.1177/135245859900500404
Abstract
Accurate, efficient measurement of disease status has become a key issue in MS clinical practice and research. Despite some perceived problems, the Expanded Disability Status Scale (EDSS) remains the most widely used comprehensive measure of impairment. There is also a place for more restricted scales of impairment which focus on some aspects of neurological function in more detail than the EDSS e.g. measures of ambulation, arm function and cognitive function. Improvements in scales of impairment in the future is likely to result from the use of more quantitative tests of selected components of the neurological examination.Keywords
This publication has 13 references indexed in Scilit:
- Meta-analysis of the placebo-treated groups in clinical trials of progressive MSNeurology, 1996
- EDMUS, a European database for multiple sclerosis.Journal of Neurology, Neurosurgery & Psychiatry, 1992
- Inter‐ and intrarater scoring agreement using grades 1.0 to 3.5 of the Kurtzke Expanded Disability Status Scale (EDSS)Neurology, 1992
- An Assessment of Disability Rating Scales Used in Multiple SclerosisArchives of Neurology, 1991
- Interrater variability with the Expanded Disability Status Scale (EDSS) and Functional Systems (FS) in a multiple sclerosis clinical trialNeurology, 1990
- THE NATURAL HISTORY OF MULTIPLE SCLEROSIS: A GEOGRAPHICALLY BASED STUDYBrain, 1989
- Scales for rating impairment in multiple sclerosisNeurology, 1988
- Interrater Reliability in Assessing Functional Systems and Disability on the Kurtzke Scale in Multiple SclerosisArchives of Neurology, 1988
- An illness severity score for multiple sclerosisNeurology, 1984
- Rating neurologic impairment in multiple sclerosisNeurology, 1983